Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study

Antioxidants are privileged candidates for the development of adjuvants able to improve the efficiency of pharmacological therapies, particularly for chronic inflammatory syndromes. During the last 20 years, anti-TNFα (tumor necrosis factor alpha) monoclonal antibodies infusion has been the biologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liso, Marina, Sila, Annamaria, Verna, Giulio, Scarano, Aurelia, Donghia, Rossella, Castellana, Fabio, Cavalcanti, Elisabetta, Pesole, Pasqua Letizia, Sommella, Eduardo Maria, Lippolis, Antonio, Armentano, Raffaele, Giudetti, Anna Maria, Vergara, Daniele, Campiglia, Pietro, Sardone, Rodolfo, Curlo, Margherita, Mastronardi, Mauro, Petroni, Katia, Tonelli, Chiara, Santino, Angelo, Chieppa, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773281/
https://www.ncbi.nlm.nih.gov/pubmed/35052642
http://dx.doi.org/10.3390/antiox11010138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773281/
https://www.ncbi.nlm.nih.gov/pubmed/35052642
http://dx.doi.org/10.3390/antiox11010138

Ejemplares similares